The results reflected the expression of most GSDM molecules differed significantly among the different ccRCC immune subtypes, which may prove that GSDM family members are a promising biomarker for ccRCC diagnosis and participate in immune regulation. This evidence concerns the gene GSDMA and nonpapillary renal cell carcinoma.